TABLE 3.
The one-stage hybrid procedure.
| Hybrid procedure | N = 30 |
| LITA-LAD | 30 (100%) |
| Ticagrelor (loading dose) | 29 (96.6%) |
| Clopidogrel (loading dose) | 1 (3.3%) |
| Acetylsalicylic acid | 100% |
| PCI ¿ 1 artery | 4 (13.3%) |
| PCI lesion type (34 lesions treated): | |
| LCx/OM | 19 |
| IM | 1 |
| RCA | 14 |
| A n (%) | 10 (29.4%) |
| B1 | 11 (32.3%) |
| B2 | 10 (29.4%) |
| C | 3 (8.9%) |
| EACAB lesion type (30 lesions treated): | |
| A n (%) | 2 (6%) |
| B1 | 4 (14%) |
| B2 | 6 (20%) |
| C | 18 (60%) |
| EES (Xience, Promus, Synergy) | 30 (88.2%) |
| ZES (Resolute) | 4 (11.8%) |
| Median number of implanted DES | 1.0 (1.0–2.0) |
| Radiation dose (mGy) | 655.0 (442.7–1047.5) |
| Fluoroscopy time (min) | 9.7 (7.9–14.2) |
| Contrast dose (ml) | 150.0 (150.0–200.0) |
Data are presented as number (percentage) and mean ± standard deviation. DES, drug eluting stent; LITA-LAD, left internal mammary artery–left anterior descending artery bypass graft; PCI, percutaneous coronary intervention.